To display releases by year, please select a year below and click Filter.
November 19, 2024
GRAIL to Participate in Upcoming Investor Conferences
View Press Release
November 18, 2024
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
View Press Release
November 12, 2024
GRAIL Reports Third Quarter 2024 Financial Results
View Press Release
November 4, 2024
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
View Press Release
October 29, 2024
GRAIL to Announce Third Quarter 2024 Financial Results
View Press Release
October 23, 2024
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference
View Press Release
October 21, 2024
GRAIL Appoints Sarah Krevans to Board of Directors
View Press Release
August 30, 2024
GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)
View Press Release
August 29, 2024
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
View Press Release
August 21, 2024
GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
View Press Release
Displaying 41 - 50 of 116